TABLE 1
Clinical study treatment assignment for PF-06282999
Cohort
Sequence
Subjects
Period 1
Period 2
Period 3
Period 4
n
mg
1
1
2
Placebo
50
125
200
2
2
20
Placebo
125
200
3
2
20
50
Placebo
200
4
2
20
50
125
Placebo